The Discounted Cash Flow (DCF) valuation of Vanda Pharmaceuticals Inc (VNDA) is 6.07 USD. With the latest stock price at 4.62 USD, the upside of Vanda Pharmaceuticals Inc based on DCF is 31.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 6.5% | 5.8% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | 4.06 - 33.96 | 6.07 |
| Upside | -12.1% - 635.1% | 31.3% |